Antidote.me

London, United States

Clinical Research Digital Health Services

Antidote is a digital health company on a mission to accelerate medical research. In a world where 80% of clinical trials are delayed or closed due to a shortage of suitable participants, Antidote uses precision recruitment to match the right patients with the right trials, striking the right balance between technology and human touch to deliver high-quality patient engagement. This is achieved through the integration of data-driven technologies, digital expertise, deep domain experience, an extensive diverse partner network, and personalized patient and site services. Antidote was launched as TrialReach and is based in the US and UK.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Antidote.me on @MedStartr Today #MedicalResearch #ClinicalTrials #AllTherapeuticAreas #DiseaseManagement #ClinicalResearch #DigitalHealthServices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/tPyVF0Rm6LY

Get Involved in Antidote.me

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2011
Website: www.antidote.me/

Disease Areas

Medical Research Clinical Trials All Therapeutic Areas Disease Management

Technologies

Digital HealthClinical Trial TechHealthcare Technology

🌐Website

What do you think of Antidote.me?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.